Circulation Reports
Online ISSN : 2434-0790
Pediatric Cardiology and Adult Congenital Heart Disease
Coronary Artery Brightness on Echocardiography as a Novel Marker in Kawasaki Disease ― Machine Learning-Based Cluster Analysis ―
Daisuke Masui, Satoru Iwashima , Yoshifumi Miyagi, Kyoko Imanaka-Yoshida, Ryuji Fukazawa, Makoto Watanabe, Yukako Yoshikane, Isao Miyairi, Takamichi Ishikawa
Author information
JOURNAL OPEN ACCESS FULL-TEXT HTML
Supplementary material

2026 Volume 8 Issue 2 Pages 306-315

Details
Abstract

Background: Coronary artery brightness (CAB) on echocardiography has been observed during the acute phase of Kawasaki disease (KD), but its clinical relevance remains unclear. This study aimed to quantify CAB and evaluate its clinical significance using unsupervised machine learning (ML).

Methods and Results: Echocardiographic still images from 89 patients with acute-phase KD were analyzed. Pixel values of the coronary arteries (CAs) were extracted and standardized as Z-scores using brightness around the right coronary cusp as a reference. Mean and median pixel intensity (Z-scores) within the coronary artery region were calculated for each major CA branch. Based on these parameters, K-means clustering stratified patients into 2 clusters. Cluster 1 had significantly greater CA diameters and Z-scores in all 3 major coronary branches, with a higher proportion of patients with a maximum CA Z-score ≥2.5. In addition, levels of total bilirubin and pentraxin 3, both known predictors of intravenous immune globulin (IVIG) resistance, were significantly higher in Cluster 1.

Conclusions: Quantitative CAB analysis combined with unsupervised ML effectively stratified KD patients into subgroups with distinct coronary and biomarker profiles. This method may serve as a novel non-invasive tool to evaluate disease severity and predict IVIG resistance in acute-phase KD.

Fullsize Image
Content from these authors
© 2026, THE JAPANESE CIRCULATION SOCIETY

This article is licensed under a Creative Commons [Attribution-NonCommercial-NoDerivatives 4.0 International] license.
https://creativecommons.org/licenses/by-nc-nd/4.0/
Previous article Next article
feedback
Top